Immix Biopharma Inc. (IMMX)
2.02
-0.04 (-1.94%)
At close: Jan 17, 2025, 3:59 PM
2.08
2.97%
After-hours Jan 17, 2025, 04:48 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 17.51M | 13.44M | 17.64M | 391.09K | 734.01K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 87.23K | 6.72K | -0.00 | -0.00 | -0.00 |
| Receivables | 1.17M | 255.71K | 25.72K | 127.44K | 175.75K |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 1.11M | 1.21M | 516.19K | 13.71K | 23.50K |
| Total Current Assets | 19.79M | 14.90M | 18.19M | 532.24K | 933.26K |
| Property-Plant & Equipment | 50.18K | 3.56K | 5.70K | 7.36K | 9.68K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 137.41K | 10.28K | 5.70K | 7.36K | 9.68K |
| Total Assets | 19.93M | 14.91M | 18.19M | 539.60K | 942.94K |
| Account Payables | 1.43M | 143.07K | 142.94K | 252.34K | 247.54K |
| Deferred Revenue | n/a | n/a | n/a | 342.84K | n/a |
| Short-Term Debt | n/a | n/a | 50.00K | 4.10M | 4.10M |
| Other Current Liabilities | 2.29M | 1.13M | 9.10K | 917.84K | 241.76K |
| Total Current Liabilities | 3.72M | 1.27M | 202.04K | 5.27M | 4.59M |
| Long-Term Debt | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | 475.00K | n/a | n/a | n/a |
| Total Long-Term Liabilities | n/a | 475.00K | n/a | n/a | n/a |
| Total Liabilities | 3.72M | 1.75M | 202.04K | 5.27M | 4.59M |
| Total Debt | n/a | n/a | 50.00K | 4.10M | 4.10M |
| Common Stock | 2.00K | 1.40K | 1.32K | 338.00 | 338.00 |
| Retained Earnings | -53.41M | -37.99M | -29.76M | -5.37M | -4.22M |
| Comprehensive Income | 134.67K | 87.02K | 125.41K | 131.86K | 68.22K |
| Shareholders Equity | 16.41M | 13.16M | 17.99M | -4.73M | -3.65M |
| Total Investments | n/a | n/a | n/a | n/a | n/a |